Akoya Biosciences Goodwill

Akoya Biosciences posts a goodwill of $18M as of March 2025. That compares with $18M in the prior-year period — up 0.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Akoya Biosciences's goodwill was $18M. The latest reading is $18M — essentially flat versus a year earlier (period ending March 2025). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of Akoya Biosciences's financial statement story. At $18M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AKYA's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Akoya Biosciences's other metric pages and overview cover the third.

Judging Akoya Biosciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in goodwill easier to interpret. Start with $18M here, then scan peer and history charts to see if the gap is persistent.